Ericksonian Hypnotherapy Just Got Its First Meta-Analysis
Eight randomised trials. 676 people. A large pooled effect, and results comparable to CBT. Here's what the evidence actually says — and what it doesn't.
The question I get asked more than any other, usually with a slightly apologetic smile, is some version of: does this actually work, or is it just vibes?
It's a fair question. For most of its history, hypnotherapy has been long on clinical stories and short on pooled data — and the Ericksonian tradition especially so, because its whole method resists standardisation. Milton Erickson's approach was indirect, conversational and tailored to the individual in front of him. That is precisely what makes it powerful in a room, and precisely what makes it awkward to put in a randomised trial.
In January 2026, that changed a little. Psychiatry International published the first systematic review and meta-analysis of Ericksonian hypnotherapy — the approach I was trained in.
What they found
Across those eight trials, Ericksonian hypnotherapy produced consistent symptom reductions compared to waitlists and standard care. More interestingly, where trials compared it directly against active treatments — cognitive behavioural therapy, motivational interviewing — the results were comparable. Not better. Comparable. In research terms that's a finding of non-inferiority, and for a modality that has spent decades outside the evidence-based conversation, it matters.
The trials spanned six very different conditions:
- Acute pain
- Depression
- Grief
- Irritable bowel syndrome
- Disordered eating
- Alcohol use
The authors also noted something that rings true from practice: the indirect, personalised quality of the Ericksonian approach may be an advantage in areas like grief and hypervigilance — the places where being told what to do tends to make people brace rather than soften.
What it doesn't say
This is the part I want to be careful about, because the temptation in my industry is to take a study like this and wave it around as proof.
The authors call it “initial empirical support”. That phrasing is deliberate, and I'm going to keep using their words rather than better ones.
Eight trials is not many. 676 people is a small pool. The trials varied in design and quality, which the review flags openly as heterogeneity. None of this tells you what will happen for you — no study can, and anyone who tells you otherwise is selling something.
What it does mean is that the ground is firmer than it was a year ago. Ericksonian work now has a place, however provisional, in the evidence-based repertoire — which is roughly what those of us using it have been arguing from clinical experience for a long time, without the numbers to back it.
Why I care about this
I sit in a slightly awkward spot. I trained in Neo-Ericksonian hypnosis, strategic psychotherapy and NLP — clinical, structured work. I also work with somatic practice and older traditions that no meta-analysis is ever going to validate. I'm not interested in pretending the second category is science, and I'm not interested in abandoning it either.
So when the clinical half of what I do gets properly examined, I want to represent that accurately — including the limits. A study that says “promising, early, needs more work” is more useful to you than one I've inflated into a guarantee.
If you've been curious about this work but wary of the claims around it, that wariness is well placed. Bring it with you.
Çınaroğlu, M., Yılmazer, E., & Noyan Ahlatcıoğlu, E. (2026). Ericksonian Hypnotherapy: A Systematic Review and Meta-Analysis of RCTs. Psychiatry International, 7(1), 16. Read it in full.
Curious whether this work fits what you're carrying? The first conversation is free, and there's no pitch in it.
Book a Session